Avidity Biosciences
RNA
#1832
Rank
S$13.93 B
Marketcap
S$92.45
Share price
0.06%
Change (1 day)
87.17%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: S$13.93 Billion

As of December 2025 Avidity Biosciences has a market cap of S$13.93 Billion. This makes Avidity Biosciences the world's 1832th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025S$13.93 B185.27%
2024S$4.88 B415.99%
2023S$0.94 B-52.14%
2022S$1.97 B31.19%
2021S$1.50 B18.95%
2020S$1.26 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Avidity Biosciences was reported to be:

S$13.93 Billion
by Nasdaq info icon info icon
S$13.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
S$7.64 B-45.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.06 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$3.01 B-78.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$3.59 B-74.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.15 B-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$14.17 B 1.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$186.74 B 1,240.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$124.15 B 791.30%๐Ÿ‡ฌ๐Ÿ‡ง UK